1. Home
  2. NATL vs SUPN Comparison

NATL vs SUPN Comparison

Compare NATL & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$40.17

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.65

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
SUPN
Founded
2023
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
NATL
SUPN
Price
$40.17
$51.65
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$42.75
$61.60
AVG Volume (30 Days)
351.2K
754.8K
Earning Date
02-26-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.74
N/A
Revenue
$4,322,000,000.00
$681,539,000.00
Revenue This Year
$2.83
$8.18
Revenue Next Year
$3.96
$22.15
P/E Ratio
$23.08
N/A
Revenue Growth
0.63
4.54
52 Week Low
$22.30
$29.16
52 Week High
$42.23
$57.65

Technical Indicators

Market Signals
Indicator
NATL
SUPN
Relative Strength Index (RSI) 56.72 61.38
Support Level $35.94 $47.29
Resistance Level $39.51 $49.71
Average True Range (ATR) 1.33 1.40
MACD 0.11 0.05
Stochastic Oscillator 93.22 100.00

Price Performance

Historical Comparison
NATL
SUPN

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: